Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Authors
Keywords
-
Journal
Lancet Gastroenterology & Hepatology
Volume 8, Issue 7, Pages 660-670
Publisher
Elsevier BV
Online
2023-04-13
DOI
10.1016/s2468-1253(23)00066-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- (2023) Mary E. Rinella et al. HEPATOLOGY
- MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death
- (2023) Emily Truong et al. Clinical Gastroenterology and Hepatology
- Two-step strategy, FIB-4 followed by magnetic resonance elastography, for detecting advanced fibrosis in NAFLD
- (2022) Nobuharu Tamaki et al. Clinical Gastroenterology and Hepatology
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Impact of non-invasive biomarkers on hepatology practice: Past, present and future
- (2022) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
- (2022) Tinsay A. Woreta et al. PLoS One
- Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants
- (2022) Veeral Ajmera et al. GASTROENTEROLOGY
- Head to head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
- (2022) Beom Kyung Kim et al. JOURNAL OF HEPATOLOGY
- Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease
- (2022) Daniel Q. Huang et al. Clinical Gastroenterology and Hepatology
- Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
- (2022) Rohit Loomba et al. GUT
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- (2022) Kiarash Riazi et al. Lancet Gastroenterology & Hepatology
- Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
- (2021) Andrea Dennis et al. Frontiers in Endocrinology
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
- (2021) Emmanuel Anandraj Selvaraj et al. JOURNAL OF HEPATOLOGY
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
- (2021) Zhong-Hua Wang et al. Hepatobiliary & Pancreatic Diseases International
- MRE plus FIB‐4 (MEFIB) versus FAST in detection of candidates for pharmacological treatment of NASH‐related fibrosis
- (2021) Nobuharu Tamaki et al. HEPATOLOGY
- Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality
- (2021) Mayu Higuchi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
- (2021) Anneli Andersson et al. Clinical Gastroenterology and Hepatology
- MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis
- (2021) Mazen Noureddin et al. JOURNAL OF HEPATOLOGY
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
- (2021) Anne Linde Mak et al. Biomedicines
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Multicenter validation of association between decline in MRI‐PDFF and histologic response in nonalcoholic steatohepatitis
- (2020) Rohit Loomba et al. HEPATOLOGY
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
- (2020) James Neuberger et al. GUT
- Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
- (2020) Yasaman Vali et al. JOURNAL OF HEPATOLOGY
- Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease
- (2020) Salvatore Petta et al. Clinical Gastroenterology and Hepatology
- Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
- (2020) Beth A. Davison et al. JOURNAL OF HEPATOLOGY
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
- (2020) Dae Ho Lee Endocrinology and Metabolism
- Change in MRI-PDFF and Histologic Response in Patients with Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
- (2020) Jonathan G. Stine et al. Clinical Gastroenterology and Hepatology
- Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation and Death in NAFLD
- (2020) Tolga Gidener et al. Clinical Gastroenterology and Hepatology
- Prognostic accuracy of FIB‐4, NAFLD fibrosis score, and APRI for NAFLD‐related events: a systematic review
- (2020) Jenny Lee et al. LIVER INTERNATIONAL
- MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
- (2020) Jinho Jung et al. GUT
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
- (2019) Arun J. Sanyal et al. HEPATOLOGY
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- Noninvasive tests accurately identify advanced fibrosis due to NASH : Baseline data from the STELLAR trials
- (2019) Quentin M. Anstee et al. HEPATOLOGY
- Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in NAFLD
- (2019) Veeral H. Ajmera et al. HEPATOLOGY
- Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
- (2019) Sarah Shili‐Masmoudi et al. LIVER INTERNATIONAL
- Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
- (2018) Stephen A. Harrison et al. GASTROENTEROLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- FIBROSpect ® NASH serum test identifies advanced liver fibrosis in patients with nonalcoholic steatohepatitis: Results of a validation study
- (2018) M. Abdelmalek et al. JOURNAL OF HEPATOLOGY
- Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- The role of 3D-MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery
- (2018) Alina M. Allen et al. HEPATOLOGY
- Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
- (2017) Charlie C. Park et al. GASTROENTEROLOGY
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study
- (2016) Rohit Loomba et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
- (2016) Stuart McPherson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
- (2016) You Zhou et al. Clinical Gastroenterology and Hepatology
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
- (2016) Kento Imajo et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
- (2014) Rohit Loomba et al. HEPATOLOGY
- Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis
- (2014) Rohit Loomba et al. JOURNAL OF LIPID RESEARCH
- Determination of reliability criteria for liver stiffness evaluation by transient elastography
- (2012) Jérôme Boursier et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now